{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:42:03Z","timestamp":1791272523945,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.urology.2009.04.088","type":"journal-article","created":{"date-parts":[[2009,10,3]],"date-time":"2009-10-03T19:45:46Z","timestamp":1254599146000},"page":"1264-1269","source":"Crossref","is-referenced-by-count":30,"title":["Expression of Stathmin in Localized Upper Urinary Tract Urothelial Carcinoma: Correlations With Prognosis"],"prefix":"10.1016","volume":"74","author":[{"given":"Wei-Chou","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Chyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chieh","family":"Chueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-How","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2009.04.088_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.urology.2009.04.088_bib2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.eururo.2007.01.038","article-title":"Long-term oncologic outcome after laparoscopic radical nephroureterectomy for upper tract transitional cell carcinoma","volume":"51","author":"Muntener","year":"2007","journal-title":"Eur Urol."},{"key":"10.1016\/j.urology.2009.04.088_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.eururo.2006.11.050","article-title":"Ureteral tumour: a specific upper urinary tract transitional cell carcinoma","volume":"51","author":"Oosterlinck","year":"2007","journal-title":"Eur Urol."},{"key":"10.1016\/j.urology.2009.04.088_bib4","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2009.04.088_bib5","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/cncr.22970","article-title":"Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers","volume":"110","author":"Novara","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2009.04.088_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/00000478-200412000-00001","article-title":"Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases","volume":"28","author":"Olgac","year":"2004","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.urology.2009.04.088_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.juro.2008.05.022","article-title":"The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0)","volume":"180","author":"Lin","year":"2008","journal-title":"J Urol."},{"issue":"2 Pt. 1","key":"10.1016\/j.urology.2009.04.088_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol."},{"key":"10.1016\/j.urology.2009.04.088_bib9","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.juro.2007.08.019","article-title":"Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically","volume":"178","author":"Saito","year":"2007","journal-title":"J Urol."},{"key":"10.1016\/j.urology.2009.04.088_bib10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.eururo.2005.07.005","article-title":"Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma","volume":"48","author":"Fromont","year":"2005","journal-title":"Eur Urol."},{"key":"10.1016\/j.urology.2009.04.088_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00428-005-0129-6","article-title":"Alpha-methylacyl-CoA racemase (AMACR\/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression","volume":"448","author":"Langner","year":"2006","journal-title":"Virchows Arch."},{"key":"10.1016\/j.urology.2009.04.088_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0463.2008.00859.x","article-title":"EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology","volume":"116","author":"Leibl","year":"2008","journal-title":"APMIS"},{"key":"10.1016\/j.urology.2009.04.088_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/gcc.2870020208","article-title":"A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1","volume":"2","author":"Ferrari","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.urology.2009.04.088_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcb.20187","article-title":"The role of stathmin in the regulation of the cell cycle","volume":"93","author":"Rubin","year":"2004","journal-title":"J Cell Biochem."},{"key":"10.1016\/j.urology.2009.04.088_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0955-0674(01)00289-7","article-title":"The oncoprotein 18\/stathmin family of microtubule destabilizers","volume":"14","author":"Cassimeris","year":"2002","journal-title":"Curr Opin Cell Biol."},{"key":"10.1016\/j.urology.2009.04.088_bib16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/path.2011","article-title":"Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma","volume":"209","author":"Yuan","year":"2006","journal-title":"J Pathol."},{"key":"10.1016\/j.urology.2009.04.088_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1074\/mcp.M200055-MCP200","article-title":"Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas","volume":"2","author":"Chen","year":"2003","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.urology.2009.04.088_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/sj.bjc.6602991","article-title":"Overexpression of stathmin in oral squamous-cell carcinoma: correlation with tumour progression and poor prognosis","volume":"94","author":"Kouzu","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2009.04.088_bib19","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1073\/pnas.0702507104","article-title":"Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity","volume":"104","author":"Saal","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.urology.2009.04.088_bib20","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pros.20601","article-title":"Increased expression and differential phosphorylation of stathmin may promote prostate cancer progression","volume":"67","author":"Ghosh","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2009.04.088_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.acthis.2007.06.002","article-title":"Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma","volume":"110","author":"Wei","year":"2008","journal-title":"Acta Histochem."},{"key":"10.1016\/j.urology.2009.04.088_bib22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0002-9440(10)64590-7","article-title":"Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis","volume":"157","author":"Hsu","year":"2000","journal-title":"Am J Pathol."},{"key":"10.1016\/j.urology.2009.04.088_bib23","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/1097-0142(20010415)91:8<1494::AID-CNCR1157>3.0.CO;2-7","article-title":"Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells","volume":"91","author":"Nishio","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2009.04.088_bib24","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1158\/1541-7786.MCR-06-0290","article-title":"Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure","volume":"5","author":"Mistry","year":"2007","journal-title":"Mol Cancer Res."},{"key":"10.1016\/j.urology.2009.04.088_bib25","first-page":"3537","article-title":"Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle","volume":"60","author":"Iancu","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.urology.2009.04.088_bib26","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/cncr.23692","article-title":"Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting","volume":"113","author":"Gallagher","year":"2008","journal-title":"Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509007560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429509007560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:35:56Z","timestamp":1558557356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429509007560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0090429509007560"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2009.04.088","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}